Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
Pharmaceutics. 2011 Nov 18;3(4):865-913. doi: 10.3390/pharmaceutics3040865.
Like any other drug, antimicrobial drugs are prone to pharmacokinetic drug interactions. These drug interactions are a major concern in clinical practice as they may have an effect on efficacy and toxicity. This article provides an overview of all published pharmacokinetic studies on drug interactions of the commonly prescribed antimicrobial drugs oxazolidinones, rifamycines, macrolides, fluoroquinolones, and beta-lactams, focusing on systematic research. We describe drug-food and drug-drug interaction studies in humans, affecting antimicrobial drugs as well as concomitantly administered drugs. Since knowledge about mechanisms is of paramount importance for adequate management of drug interactions, the most plausible underlying mechanism of the drug interaction is provided when available. This overview can be used in daily practice to support the management of pharmacokinetic drug interactions of antimicrobial drugs.
与其他药物一样,抗菌药物也容易发生药代动力学药物相互作用。这些药物相互作用在临床实践中是一个主要关注点,因为它们可能会对疗效和毒性产生影响。本文综述了所有已发表的关于常用抗菌药物(包括恶唑烷酮类、利福霉素类、大环内酯类、氟喹诺酮类和β-内酰胺类)药代动力学相互作用的研究,重点是系统研究。我们描述了在人类中药物-食物和药物-药物相互作用的研究,这些相互作用会影响抗菌药物以及同时给予的药物。由于了解机制对于药物相互作用的合理管理至关重要,因此在有可用信息时,我们会提供药物相互作用最合理的潜在机制。该综述可用于日常实践,以支持抗菌药物药代动力学药物相互作用的管理。